✦ LIBER ✦

High hENT1 expression is predictive of response of to adjuvant gemcitabine for pancreatic ductal adenocarcinoma patients randomized to adjuvant therapies in the ESPAC trials

✍ Scribed by Neoptolemos, J.P.; Cox, T.F.; Greenhalf, W.; Garner, L.; Campbell, F.; Ghaneh, P.; Palmer, D.; Mackey, J.; Dervenis, C.; Scarpa, A.; Bassi, C.; Büchler, M.W.

Book ID: 122926696
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 45 KB
Volume: 13
Category: Article
ISSN: 1424-3903
DOI: 10.1016/j.pan.2012.12.075

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nucleotide transporters and dCK1 as prog

Nucleotide transporters and dCK1 as prognostic markers for patients with resected pancreatic ductal adenocarcinoma with or without adjuvant gemcitabine or 5FU hENT1 tested with samples from patients randomized in the ESPAC1/3 trials

✍ Neoptolemos, J.P.; Cox, T.F.; Greenhalf, W.; Garner, L.; Campbell, F.; Palmer, D 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 58 KB

Modeling interactions between human equi

Modeling interactions between human equilibrative nucleoside transporter-1 (hENT-1) and other factors involved in the response to gemcitabine treatment to predict of clinical outcomes, in pancreatic ductal adenocarcinoma (PDAC) patients.

✍ Pazienza, Valerio; Tavano, Francesca; Fontana, Andrea; Pellegrini, Fabio; France 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 51 KB